Thermo Fisher Scientific Establishes RNAi Discovery Grant Program to Advance Gene Research
News Aug 14, 2009
Thermo Fisher Scientific Inc. has announced that it has established a grant program to award life science researchers more than $400,000 in RNA-interference (RNAi) reagents used to study genes in medical research and drug discovery.
The Thermo Scientific Discovery Grant Program will include various siRNA, shRNA and microRNA reagents from the industry-leading Dharmacon and Open Biosystems RNAi technology portfolios, marketed under the Thermo Scientific brand. Five projects will be selected based on their potential to advance science and medicine.
Recent breakthroughs involving Thermo Scientific RNAi technologies include a study to find human genes associated with West Nile virus infection, the discovery of potential new targets for HIV drugs and identification of genes that appear to affect the susceptibility of human cancer cells to certain chemotherapy treatments.
“Thermo Fisher is a world leader in providing tools for gene analysis, and we have led the way in the use of RNAi technologies for scientific research,” said Marc N. Casper, chief operating officer of Thermo Fisher Scientific. “We have created this grant program to advance RNAi-based screening and to help our life sciences customers accelerate their discoveries.”
The Thermo Scientific RNAi Discovery Grant Program is open to both academic and commercial researchers, who may complete a simple application online at www.thermo.com/RNAiDiscovery.
Grant applications will be reviewed by a panel of scientists at Thermo Fisher Scientific, and recipients will be selected based on the merit of their projects, their screening capabilities and, most importantly, potential scientific impact. Applications for the grants will be accepted through September 7, 2009.
Genes Can Influence the Mutation, Activity of Nearby GenesNews
Study shows that a gene’s neighborhood can influence whether and how the activity of a gene changes.READ MORE
Brain Regions Implicated in Mental Disorders Influenced by Neanderthal GenesNews
Findings indicate that the more a person’s genome carries genetic vestiges of Neanderthals, the more certain parts of his or her brain and skull resemble those of humans’ evolutionary cousins that went extinct 40,000 years ago.READ MORE
Acquisition Sees Agilent Gain Powerful NGS IP PortfolioNews
Agilent Technologies announces its acquisition of the molecular and sample barcoding portfolios of Population Genetics Technologies.READ MORE
Comments | 0 ADD COMMENT
International Conference on Genomics and Pharmacogenomics
Jul 18 - Jul 19, 2018
EMBL Course: Next Generation Sequencing: RNA Sequencing Library Preparation
Apr 23 - Apr 27, 2018
EMBO Practical Course: Microbial Metagenomics: A 360º Approach
Apr 23 - Apr 30, 2018